logo

Zai Lab Limited (ZLAB)



Trade ZLAB now with
  Date
  Headline
8/4/2020 7:53:56 AM Zai Lab: China's NMPA Granted Priority Review Status To NDA For Ripretinib
7/20/2020 7:40:23 AM Zai Lab And Deciphera Pharma: China NMPA Accepts NDA For Ripretinib For Advanced Gastrointestinal Stromal Tumor
7/7/2020 7:40:34 AM Turning Point Therapeutics And Zai Lab Announce License Agreement For Repotrectinib In Greater China
5/28/2020 7:51:42 AM Zai Lab Announces NORA Study Meets All Primary And Secondary Endpoints
4/16/2020 7:42:10 AM Zai Lab Announces China’s NMPA Grants Priority Review To SNDA For ZEJULA
4/16/2020 7:40:28 AM Zai Lab Announces China's NMPA Grants Priority Review To SNDA For ZEJULA
4/8/2020 6:02:01 AM Regeneron And Zai Lab Announce Regional Strategic Collaboration For REGN1979
3/19/2020 7:34:10 AM Zai Lab FY Loss Per Share $2.64 Vs Loss $3.03 Last Year
2/10/2020 7:39:59 AM Zai Lab Announces China NMPA Accepts NDA For Omadacycline
1/14/2020 7:33:34 AM Zai Lab Appoints Lonnie Moulder To Its Board
1/9/2020 7:37:59 AM Zai Lab, Novocure Say First Patient Enrolled In Phase 2 Pilot Trial Of Tumor Treating Fields Together With Chemotherapy
1/9/2020 7:34:16 AM Zai Lab, Novocure : First Patient Enrolled In Phase 2 Pilot Trial Of Tumor Treating Fields Together With Chemotherapy
12/27/2019 7:54:47 AM Zai Lab Reports NMPA Approval Of ZEJULA In China As Maintenance Therapy For Patients With Recurrent Ovarian Cancer
12/16/2019 7:36:27 AM Zai Lab Appoints Timothy Yap To Its Scientific Advisory Board
10/25/2019 8:36:49 AM Zai Lab Partner, MacroGenics Begin Phase 2/3 MAHOGANY Study Of Margetuximab In Gastric Junction Cancer
7/2/2019 7:35:18 AM Incyte And Zai Lab Announce Collaboration And License Agreement For INCMGA0012 In Greater China
6/11/2019 7:09:14 AM Deciphera Pharma And Zai Lab Announce Exclusive License Agreement For Ripretinib In Greater China